
SLAM Bio Appoints Chan Whiting, PhD, as Chief Scientific Officer to Lead Next-Generation Tumor-Targeting Immunotherapies
Dr. Whiting brings 20+ years of experience advancing immunotherapies from discovery to clinical trials across top biotech companies WESTLAKE VILLAGE, CA, UNITED STATES, May 5, 2025 /EINPresswire.com/ -- SLAM BioTherapeutics, a biotechnology …